On NoticeOn Notice
← Bills

Therapeutic Goods (Charges) Amendment Bill 2026

Unknown
16 November 2026 · 3 days agoExplanatory Memorandum →

Summary

The Therapeutic Goods Administration currently charges fees to companies that want to register medicines, medical devices, and other health products in Australia. This amendment changes how those charges work — adjusting the fees that manufacturers and importers must pay when they submit products for approval or renewal. The changes affect anyone bringing therapeutic goods to market in Australia, from large pharmaceutical companies to smaller health product businesses, and may alter the cost of bringing new treatments to Australian patients by making the registration process more or less expensive depending on the product type.

Bill Progress

Senate

First Reading

Second Reading

Committee of the Whole

Third Reading

House of Representatives

First Reading

Second Reading

Consideration in Detail

Third Reading

Royal Assent

Royal Assent